George Mells

6.8k total citations
57 papers, 2.0k citations indexed

About

George Mells is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, George Mells has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hepatology, 39 papers in Epidemiology and 21 papers in Surgery. Recurrent topics in George Mells's work include Liver Diseases and Immunity (44 papers), Liver Disease Diagnosis and Treatment (37 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). George Mells is often cited by papers focused on Liver Diseases and Immunity (44 papers), Liver Disease Diagnosis and Treatment (37 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). George Mells collaborates with scholars based in United Kingdom, Canada and Italy. George Mells's co-authors include James Neuberger, Graeme Alexander, Richard Sandford, D. I. Jones, Michael A. Heneghan, Darren B. Day, Samantha Ducker, Julia L. Newton, Muhammad F. Dawwas and Marco Carbone and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

George Mells

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Mells United Kingdom 22 1.5k 1.1k 850 282 198 57 2.0k
Rodrigo Liberal Portugal 27 1.5k 1.0× 1.3k 1.2× 567 0.7× 141 0.5× 97 0.5× 84 2.4k
Tobias J. Weismüller Germany 19 670 0.5× 415 0.4× 867 1.0× 188 0.7× 396 2.0× 65 1.4k
Minneke J. Coenraad Netherlands 20 877 0.6× 819 0.7× 472 0.6× 79 0.3× 193 1.0× 78 1.4k
James D. Eason United States 24 1.1k 0.7× 699 0.6× 1.1k 1.3× 128 0.5× 78 0.4× 61 2.3k
Douglas Quan Canada 25 658 0.4× 227 0.2× 738 0.9× 292 1.0× 155 0.8× 64 1.5k
Giuseppe Fusai United Kingdom 31 740 0.5× 740 0.7× 1.2k 1.4× 1.2k 4.1× 578 2.9× 71 2.6k
Yuzo Umeda Japan 26 680 0.5× 377 0.3× 1.0k 1.2× 791 2.8× 368 1.9× 167 2.0k
Marta Piqueras Spain 23 285 0.2× 697 0.6× 379 0.4× 168 0.6× 238 1.2× 67 1.7k
Satoshi Miuma Japan 20 551 0.4× 501 0.4× 181 0.2× 156 0.6× 71 0.4× 104 1.2k
Esra Erden Türkiye 20 445 0.3× 680 0.6× 281 0.3× 125 0.4× 91 0.5× 90 1.3k

Countries citing papers authored by George Mells

Since Specialization
Citations

This map shows the geographic impact of George Mells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Mells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Mells more than expected).

Fields of papers citing papers by George Mells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Mells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Mells. The network helps show where George Mells may publish in the future.

Co-authorship network of co-authors of George Mells

This figure shows the co-authorship network connecting the top 25 collaborators of George Mells. A scholar is included among the top collaborators of George Mells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Mells. George Mells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbas, Nadir, Rachel A. Smith, Neil Halliday, et al.. (2025). Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis. Alimentary Pharmacology & Therapeutics. 63(4). 494–506.
2.
Costello, Ruth, Rachel J. Smith, George Mells, et al.. (2024). Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform. SHILAP Revista de lepidopterología. 4(1). 238–238.
3.
Smith, Rachel J., Nadir Abbas, Steve Flack, et al.. (2022). O07 Results of the first national audit of PBC management reveal significant variation in care delivery across the UK. Abstracts. A5.1–A5.
4.
Jones, David, Laura Ogle, George Mells, et al.. (2022). The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study. EBioMedicine. 80. 104068–104068. 8 indexed citations
5.
Ogle, Laura, George Mells, Jonathan Badrock, et al.. (2021). The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis. Hepatology. 74(6). 3269–3283. 21 indexed citations
6.
Hitomi, Yuki, Yoshihiro Aiba, Kazuko Ueno, et al.. (2021). rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis. Journal of Autoimmunity. 126. 102775–102775. 7 indexed citations
7.
Rice, Stephen, Viviana Albani, Gulnar Fattakhova, et al.. (2020). Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom. Clinical Gastroenterology and Hepatology. 19(4). 768–776.e10. 14 indexed citations
8.
Casey, Ruth, Olivier Giger, Ian Seetho, et al.. (2018). Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab. Seminars in Oncology. 45(3). 151–155. 23 indexed citations
9.
Liaskou, Evaggelia, Samita R. Patel, Gwilym J. Webb, et al.. (2018). Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells. Journal of Autoimmunity. 94. 143–155. 45 indexed citations
10.
Hegade, Vinod S., George Mells, Holly Fisher, et al.. (2018). Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom. Clinical Gastroenterology and Hepatology. 17(7). 1379–1387.e3. 51 indexed citations
11.
Gerussi, Alessio, et al.. (2018). Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews. 17(9). 854–865. 24 indexed citations
12.
Fisher, Holly, Deborah Stocken, Stephen Rice, et al.. (2018). The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility. Hepatology. 68(4). 1487–1497. 50 indexed citations
13.
Kim, Jin Un, Vijay P.B. Grover, Louise Southern, et al.. (2017). Early Primary Biliary Cholangitis is Characterised by Brain Abnormalities on Cerebral Magnetic Resonance Imaging. Journal of Clinical and Experimental Hepatology. 7. S28–S29. 1 indexed citations
14.
Carbone, Marco, Vincenzo Ronca, Savino Bruno, Pietro Invernizzi, & George Mells. (2016). Toward precision medicine in primary biliary cholangitis. Digestive and Liver Disease. 48(8). 843–850. 13 indexed citations
15.
Pencek, Richard, Tracy J. Mayne, Marco Carbone, et al.. (2015). Parallel 23: Fatty Liver Disease: Clinical and Therapeutic I. Hepatology. 62(S1). 288A–291A. 2 indexed citations
16.
Mells, George & Gideon M. Hirschfield. (2015). Making the most of new genetic risk factors – genetic and epigenetic fine mapping of causal autoimmune disease variants. Clinics and Research in Hepatology and Gastroenterology. 39(4). 408–411. 6 indexed citations
17.
Pells, Greta, George Mells, Marco Carbone, et al.. (2013). The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. Journal of Hepatology. 59(1). 67–73. 46 indexed citations
18.
Mells, George, James Floyd, Katherine I. Morley, et al.. (2011). Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genetics. 43(4). 329–332. 332 indexed citations
19.
Mells, George & James Neuberger. (2008). Protocol Liver Allograft Biopsies. Transplantation. 85(12). 1686–1692. 30 indexed citations
20.
Mells, George, et al.. (2006). UK acquired hepatitis E—An emerging problem?. Journal of Medical Virology. 78(4). 473–475. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodrigo Liberal Breakdown of academic impact, for papers by Tobias J. Weismüller Breakdown of academic impact, for papers by Minneke J. Coenraad Breakdown of academic impact, for papers by James D. Eason Breakdown of academic impact, for papers by Douglas Quan Breakdown of academic impact, for papers by Giuseppe Fusai Breakdown of academic impact, for papers by Yuzo Umeda Breakdown of academic impact, for papers by Marta Piqueras Breakdown of academic impact, for papers by Satoshi Miuma Breakdown of academic impact, for papers by Esra Erden
Rankless by CCL
2026